Even after combining these conditions with IGF-1, the diagnostic power of IGF-1 for GHD screening did not increase
The semaglutide versus tirzepatide dosage comparison shows that tirzepatide achieves greater weight loss at its maximum dose than semaglutide does at its maximum dose, while potentially being better tolerated because the GIP pathway carries less gastrointestinal burden
If pregnant, trying to conceive or breastfeeding, seek medical advice before use
Following FDA clearance of its IND application, the randomized, double-blind, single ascending dose study will evaluate the safety, tolerability, and body weight changes in healthy adults with a BMI of 30 or greater
This distinction is important for transparency and ensures you are fully informed about your treatment options